niacinamide has been researched along with Keratosis in 5 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Keratosis: Any horny growth such as a wart or callus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib, a multitargeted kinase inhibitor used for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinomas, received FDA approval in 2005." | 3.75 | Localized dyskeratotic plaque with milia associated with sorafenib. ( Burkemper, NM; Chappell, JA; Semchyshyn, N, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, P | 1 |
| Yan, H | 1 |
| Chen, X | 1 |
| Zhang, Y | 1 |
| Zhao, Z | 1 |
| Cao, J | 1 |
| Zhu, Y | 1 |
| Du, J | 1 |
| Xu, Z | 1 |
| Zhang, X | 1 |
| Zeng, S | 1 |
| Yang, B | 1 |
| Ma, S | 1 |
| He, Q | 1 |
| Frigerio, M | 1 |
| Santi, V | 1 |
| Di Micoli, A | 1 |
| Trevisani, F | 1 |
| Chappell, JA | 1 |
| Burkemper, NM | 1 |
| Semchyshyn, N | 1 |
| Franck, N | 1 |
| Barete, S | 1 |
| Moguelet, P | 1 |
| Blanchet, B | 1 |
| Carlotti, A | 1 |
| Ropert, S | 1 |
| Avril, MF | 1 |
| Francès, C | 1 |
| Billemont, B | 1 |
| Goldwasser, F | 1 |
| Lacouture, ME | 1 |
| Desai, A | 1 |
| Soltani, K | 1 |
| Petronic-Rosic, V | 1 |
| Laumann, AE | 1 |
| Ratain, MJ | 1 |
| Stadler, WM | 1 |
5 other studies available for niacinamide and Keratosis
| Article | Year |
|---|---|
s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide.
Topics: Aged; Aged, 80 and over; Animals; Disease Models, Animal; Endothelial Cells; Female; Foot; HaCaT Cel | 2020 |
Hyperkeratosis of nipple skin during sorafenib treatment.
Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Breast Diseases; Carcinoma, Hepatocellular; Humans; | 2009 |
Localized dyskeratotic plaque with milia associated with sorafenib.
Topics: Acantholysis; Benzenesulfonates; Carcinoma, Hepatocellular; Diabetes Mellitus; Drug Eruptions; Hepat | 2009 |
Spiny follicular hyperkeratosis eruption: a new cutaneous adverse effect of sorafenib.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Benzenesulfonates; Drug Eruptions; Female; | 2010 |
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor.
Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Humans; Keratosis; Male; Middle Aged; Niac | 2006 |